Every four minutes someone in the US is diagnosed with a blood cancer. It might be lymphoma or leukemia, myeloma or myelodysplastic syndromes (MDS). While we have made great strides in treating some of these over the years, we still have a long way to go. Need proof? Well, every nine minutes someone in the US … Continue reading New stem cell approach targeting deadly blood cancers
FDA
Timing is everything: could CRISPR gene editing push CIRM to change its rules on funding stem cell research?
Talk about timely. When we decided, several months ago, to hold a Standards Working Group (SWG) meeting to talk about the impact of CRISPR, a tool that is transforming the field of human gene editing, we had no idea that our meeting would fall smack in the midst of a flurry of news stories about … Continue reading Timing is everything: could CRISPR gene editing push CIRM to change its rules on funding stem cell research?
If you want to accelerate stem cell therapies then create an Accelerating Center
“You can’t teach fish to fly,” is one of the phrases that our CIRM President & CEO, Randy Mills, likes to throw out when asked why we needed to create new centers to help researchers move their most promising therapies out of the lab and into clinical trials. His point is that many researchers are … Continue reading If you want to accelerate stem cell therapies then create an Accelerating Center
Doing nothing is not OK: A call for change at the FDA
The US Food and Drug Administration (FDA) is caught between a rock and a hard place. And CIRM is going to try and help them get out from under that. As things stand today, if the FDA approves a therapy quickly and a patient later dies from it, then they are widely criticized. If they … Continue reading Doing nothing is not OK: A call for change at the FDA
Why “Right to Try” laws are more feel good than do good
L to R: Don Gibbons, CIRM; Jeanne Loring; Beth Roxland; Aaron Levine In the last few years some 24 states have approved so-called “Right to Try” laws. These are intended to give terminally ill patients faster and easier access to experimental therapies. But a panel of experts at the World Stem Cell Summit in Atlanta … Continue reading Why “Right to Try” laws are more feel good than do good
Call to Action by FDA at World Stem Cell Summit
FDA Deputy Commissioner Dr. Robert Califf talking at the World Stem Cell Summit The World Stem Cell Summit annual conference in Atlanta kicked off today with a clarion call from Dr. Robert Califf, the Deputy Commissioner for the Food and Drug Administration. He told the audience: “We want you to accelerate translation to produce safe … Continue reading Call to Action by FDA at World Stem Cell Summit
CIRM-funded clinical trial for spinal cord injury reports promising results
Today, the Menlo Park-based biotech company Asterias Biotherapeutics reported positive results from the first three patients treated in its Phase 1/2a clinical study using stem cell therapy to treat patients with spinal cord injury. This trial is funded by a CIRM Strategic Partnerships Award grant of $14.3 million. Asterias has developed a stem cell therapy … Continue reading CIRM-funded clinical trial for spinal cord injury reports promising results
Cell mate: the man who makes stem cells for clinical trials
When we announced that one of the researchers we fund - Dr. Henry Klassen at the University of California, Irvine - has begun his clinical trial to treat the vision-destroying disease retinitis pigmentosa, we celebrated the excitement felt by the researchers and the hope from people with the disease. But we missed out one group. … Continue reading Cell mate: the man who makes stem cells for clinical trials
Da Mayor and the clinical trial that could help save his vision
Former San Francisco Mayor and California State Assembly Speaker Willie Brown is many things, but shy is not one of them. A profile of him in the San Francisco Chronicle once described him as “Brash, smart, confident”. But for years Da Mayor – as he is fondly known in The City – said very little … Continue reading Da Mayor and the clinical trial that could help save his vision
One man’s story points to hope against a deadly skin cancer
One of the great privileges and pleasures of working at the stem cell agency is the chance to meet and work with some remarkable people, such as my colleagues here at CIRM and the researchers we support. But for me the most humbling, and by far the most rewarding experience, is having a chance to … Continue reading One man’s story points to hope against a deadly skin cancer
The Stem Cellar 